GSK signs licence deals with three generics firms to make HIV preventative for low income countries

30-03-2023

Liz Hockley

GSK signs licence deals with three generics firms to make HIV preventative for low income countries

Willy Barton / Shutterstock.com

The three companies will make low-cost versions of HIV PrEP drug | Generics will be available to consumers in 90 low- and middle-income countries.


GSK, Medicines Patent Pool, Aurobindo, Cipla, Viatris, HIV, Apretude, cabotegravir, licensing

LSIPR